Journals / Adnan Menderes Üniversitesi Tıp Fakültesi Dergisi / 2006 / Cilt: 7 - Sayı: 3

Analysis of patients with Henoch-Schönlein purpura

Henoch-Schönlein purpuralı hastaların analizi

Pages
39–43
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Complicatios and sequeles are infrequent.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The aim of this study was to investigate the clinical and epidemiologic features, laboratory finding and outcome of disease in our patients with Henoch-Schönlein purpura.Methods: Fourty-five patients with Henoch-Schönlein purpura who were diagnosed and observed in our department of pediatrics between 2000-2006 were retrospectively evaluated.Results: Twentyseven (60.0%) of the patients were female and 18 (40.0%) were male, female to male ratio was 1.5.
📊
Key Findings & Data:Mean age of the patients was 6 year 9 months (8 months-14 years).
💡
Conclusion & Impact:Complicatios and sequeles are infrequent.
🔬Design:Research Article
📍Scope:2000-2006 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: The aim of this study was to investigate the clinical and epidemiologic features, laboratory finding and outcome of disease in our patients with Henoch-Schönlein purpura.Methods: Fourty-five patients with Henoch-Schönlein purpura who were diagnosed and observed in our department of pediatrics between 2000-2006 were retrospectively evaluated.Results: Twentyseven (60.0%) of the patients were female and 18 (40.0%) were male, female to male ratio was 1.5. Mean age of the patients was 6 year 9 months (8 months-14 years). Initial symptoms and findings in the time of admission with decreasing frequency were purpura (100%), disability to walk and/or arthralgia (71.1%) ve stomachache (40.0%). An infection history was present in 57.7% of the patients in the last 12 days. In physical examination, purpura (lower extremity and hips 100%, diffuse 11.1%), arhtritis (32 patients, 71.1%, mostly diffused on ankle and knee), fever (9 patients, 20,0%) were discovered. Anaemia (8/45 patients, 17.7%), leukocytosis (6/45 patients, 13.3%), trombocytosis (16/45 patients, 35.5%), increased erythrocyte sedimentation rate (16/25 patients, 64.0%), positive CRP (33/34 patients, 97.0%), hematuria (4/45 patients, 8.8%), proteinuria (2/45 patients, 4.4%), positive fecal blood tests (14/42 patients, 33.3%) were determined. Renal biopsy was not needed as there was no persistant hematuria and proteinuria. 17 patients who had gastrointestinal involvement were treated with steroid therapy for a mean period of 9.1 days. Perforation and invagination was not observed. Relapse was seen in 9 patients. (mean duration 15th day). There was no nervous system involvement in any patients.Conclusion: Henoch-Schonlein Purpura is a frequent benign disease of childhood. Complicatios and sequeles are infrequent.

Özet

Amaç: HSP'li hastalarımızın epidemiyolojik ve klinik özellikleri, laboratuar bulguları ve hastalığın seyrinin incelenmesi amaçlandı.Yöntem: 2000-2006 yılları arasında, hastanemiz Çocuk Sağlığı ve Hastalıkları Kliniği'nde Henoch-Schonlein Purpurası tanısı alan ve izlenen 45 hasta retrospektif olarak incelendi.Bulgular: Hastaların 27 (%60,0)'si kız, 18 (%40,0)'i erkek, kız / erkek oranı 1.5 idi.Yaş ortalaması 6 yaş 9 ay (8 ay-14 yaş) olarak saptandı. Basvuru şikayetleri sıklık sırasına göre döküntü (%100), yürüyememe ve/veya eklem agrısı (%71,1) ve karın ağrısı (%40,0) idi. Hastaların % 57,7'inde ortalama 12 gün önce geçirilmiş enfeksiyon öyküsü tespit edildi. Fizik muayenede purpurik döküntü (alt ekstremite ve gluteal bölgede %100, yaygın %11,1), artrit (32 hastada, %71,1, en sık ayak bileği ve diz eklemlerinde), ateş (9 hastada, %20,0) bulundu. Laboratuar bulguları anemi (8/45 hasta, %17,7), lökositoz (6/45 hasta, %13,3), trombositoz (16/45 hasta, %35,5), sedimentasyon yüksekliği (16/25 hasta, %64,0), CRP pozitifliği (33/34 hasta, %97,0), hematüri (4/45 hasta, %8,8), proteinüri (2/45 hasta, %,4,4), gaitada gizli kan pozitifliği (14/42 hasta, %33,3) bulundu. Hematüri ve proteinüri devam etmediği için hiçbir hastada böbrek biyopsisine gerek duyulmadı. Gastrointestinal sistem tutulumu olduğu düşünülen 17 hastaya steroid tedavisi başlandı ve ortalama 9.1 gün kullanıldı. Perforasyon, invaginasyon gözlenmedi. Ortalama 15. günde 9 hastada relaps görüldü. Santral sinir sistemi tutulumu hiçbir hastada yoktu.Sonuç: Henoch-Schonlein Purpurası çocukluk çağında sık görülen benign karakterli bir hastalık olup komplikasyon ve sekel oranı oldukça düşüktür.

🔖

Cite This Article

ERGİN, H., HALİS, H., KILIÇ, İ., CİNBİŞ, M., SEMİZ, S., CANDEMİR, M., POLAT, A. (2022). Analysis of patients with Henoch-Schönlein purpura. Adnan Menderes Üniversitesi Tıp Fakültesi Dergisi, Cilt: 7 - Sayı: 3, 39–43. https://ajindex.com/articles/429017

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Ozen S, Bakkaloglu A, Dusunsel R, Soylemezoglu O, Ozaltin F, Poyrazoglu H. et all. Childhood vasculitides in Turkey: a nationwide survey. Clin Rheumatol 2006: Apr 4
  2. Michael LM, Lauren MP. Vasculitis syndromes. In: Behrman RE, Kliegman RM, Jenson HB, eds. Nelson Textbook of Pediatrics. 17th ed, Philadelphia: WB Saunders Co, 2004: 826-9
  3. Kim S, Dedeoglu F. Update on pediatric vasculitis. Curr Opin Pediatr 2005; 17:695-702
  4. Tsuboi H, Takemura T, Katsuoka K.Acase of Henoch- Schonlein purpura temporarily improved by hemodialysis. J Dermatol. 2006; 33:281-6
  5. Ilan Y, Naparstek Y. Henoch Schonlein purpura in children and adults: Is it one entity?. Semin Arthritis Rheum 2002; 32:139-40
  6. Soylu A, Kavukçu S. Henoch-Schönlein purpura in childhood: Pathophysiology, diagnosis and treatment. SSK Tepecik Hast Derg 2004; 14:71-81
  7. Sandra T, Annalisa M, Francesca G, Massimo R. et all. Henoch-Schonlein purpura in childhood: Epidemiological and clinical analysis of 150 cases over a 5-year period and review of Literature. Semin Arthritis Rheum 2005; 35:143-53
  8. Szer IS. Henoch-Schonlein purpura. Curr Opin Rheumatol 1994; 6:25-31
  9. Altinkaynak S, Ertekin V, Selimoglu MA. J Emer Med. 2006; 30:21921
  10. Tizard EJ. Henoch-Schoenlein purpura. Arch Dis Child 1999; 80:3803
  11. Aydın M, Demirol M, Kurt A, Kurt NAC, Yılmaz E. The evaluation of the our patients with Henoch- Schönlein purpura. Çocuk Dergisi 2005; 5:249-53
  12. Kaku Y, Nohara K, Honda S. Renal involvement in Schonlein-Henoch Purpura: a multivariate analysis of prognostic factors. Kidney Int 1998; 53:1755-59
  13. Kendirli T, Yalcinkaya F, Ileri M, Ozcakar ZB, Ekim E. HenochSchonlein purpura in Turkish children. Journal of Ankara Medical School. 2004; 26: 7-11 14) Rosenblum ND, Winter HS. Steroid effects on the course of abdominal pain in children with Henoch- Schonlein Purpura. Pediatrics 1987; 79:1018-21
  14. Glasier CM, Siegel MJ, Mc Alister WH, Shackelford GD. Henoch Schonlein syndrome in children: gastrointestinal manifestations. Am J Roentgenol 1981; 136:1081-5
  15. Ballinger S. HenochSchonlein Purpura. Curr Opin Rheumatol 2003; 15:5914
  16. Shin JI, Park JM, Shin YH, Kim JH, Lee JS, Jeong HJ. HenochSchönlein purpura nephritis with nephroticrange proteinuria: histological regression possibly associated with cyclosporin A and steroid treatment Scand J Rheumatol 2005; 34:3925
  17. Gonzalez-Gay MA, Llorca J. Controversies on the use of corticosteroid therapy in children with Henoch- Schönlein